Colorectal cancer (CRC) is the third most common cancer worldwide and a leading cause of
death, with burden expected to increase in the coming years. Enhanced adiposity …

Visceral adipose tissue (VAT) is a main site where metabolic and immunologic processes
interplay to regulate, at local and systemic level, the inflammatory status and immune …

Inflammation and altered immune response are important components of obesity and
contribute greatly to the promotion of obesity-related metabolic complications, especially …

Obesity and its accompanying comorbidities, including cancer, are rising worldwide. Obesity
is caused by a prolonged state of the high caloric consumption and the low energy …

Obesity-associated inflammation stems from a combination of cell-intrinsic changes of
individual immune cell subsets and the dynamic crosstalk amongst a broad array of immune …

The increased prevalence of obesity worldwide has been accompanied by increases in risk
and rates of obesity‐associated metabolic dysfunctions, such as insulin resistance. The …

The immune system has previously been demonstrated to be associated with the
pathophysiological development of metabolic abnormalities. However, the mechanisms …

Obesity is a low-grade chronic inflammatory state representing an important risk factor for
colorectal cancer (CRC). Adipocytes strongly contribute to inflammation by producing …

Due to its prevalence, obesity is now considered a global epidemic. It is linked to increased
risk of colorectal cancer, the third most common cancer and the second leading cause of …

Obesity, a growing chronic metabolic disease, greatly increases the risk of metabolic
syndrome which includes type 2 diabetes, fatty liver and cardiovascular diseases. Obesity …